Dynocardia

About:

Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.

Website: https://www.dynocardia.care/

Top Investors: National Science Foundation, Luminate, National Heart, Lung and Blood Institute, Massachusetts Medical Device Development Center (M2D2), Mayo Clinic Platform

Description:

Dynocardia, a biomedical device development company, committed to satisfying critical unmet needs to improve healthcare. It offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. The company was founded in 2018 and headquartered in Lowell, Massachusetts.

Total Funding Amount:

$5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Abhijit Biswas, Edward Adelson, Mohan Thanikachalam

Number of Employees:

1-10

Last Funding Date:

2024-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai